UMB Students Roll Up Sleeves, Administer Vaccines
January 19, 2021
Pharmacy, nursing students volunteer at COVID-19 vaccination clinic.
Ninth Annual M-CERSI Regulatory Science Competition Goes Virtual
January 19, 2021
Second-year student pharmacists awarded first place in contest that aims to promote student interest in the field of regulatory science.
SOP Alum to Address Double Pandemics in MLK Celebration Speech
January 13, 2021
Anthony Wutoh, provost and chief academic officer at Howard University, says we must work together for our collective future and the good of society.
Ninth Annual M-CERSI Regulatory Science Competition Goes Virtual
January 19, 2021
Second-year student pharmacists awarded first place in contest that aims to promote student interest in the field of regulatory science.
UMB Students Roll Up Sleeves, Administer Vaccines
January 19, 2021
Pharmacy, nursing students volunteer at COVID-19 vaccination clinic.
SOP Alum to Address Double Pandemics in MLK Celebration Speech
January 13, 2021
Anthony Wutoh, provost and chief academic officer at Howard University, says we must work together for our collective future and the good of society.
Study Examines Projected Health and Economic Burden of COPD in the U.S.
December 18, 2020
Research led by Dr. Zafar Zafari will help inform future studies and guide policy decisions to reduce health care and economic costs associated with COPD in the U.S.
The PATIENTS Program Kicks-Off New Fundraising Campaign with Virtual Event
November 25, 2020
Key stakeholders from The PATIENTS Program come together to celebrate past achievements and look towards future successes.
SOP’s Qato Selected for National Leadership Program
November 24, 2020
The Robert Wood Johnson Foundation’s Culture of Health Leaders program will provide Dr. Danya Qato with the tools to support her development as an agent of change for health equity and structural transformation.
UMSOP and KamTek Collaborate on Therapeutic Development to Treat Deadly Infections
November 23, 2020
Award from the Maryland Industrial Partnerships (MIPS) program supports work to formulate Clofazimine for treatment of recurrent C. difficile infections.